 Elanco Animal Health Inc NYSE: ELAN has reported Q2 EPS of 0.28 higher than 0.09 reported a year ago, surpassing analysts estimate of 0.26 and the company guidance of 0.22 - 0.27. Sales of 1.28 billion, 118 YY, were above the guidance range of 1.23 - 1.26 billion, beating the consensus estimate of 1.23 billion. 